Literature DB >> 24363518

Role of the advanced glycation end products receptor in Crohn's disease inflammation.

Rachele Ciccocioppo1, Alessandro Vanoli1, Catherine Klersy1, Venerina Imbesi1, Vincenzo Boccaccio1, Rachele Manca1, Elena Betti1, Giuseppina Cristina Cangemi1, Elena Strada1, Roberta Besio1, Antonio Rossi1, Colomba Falcone1, Sandro Ardizzone1, Paolo Fociani1, Piergiorgio Danelli1, Gino Roberto Corazza1.   

Abstract

AIM: To investigate the level of mucosal expression and the involvement of the receptor for the advanced glycation end products (RAGE) in delayed apoptosis and tumor necrosis factor (TNF)-α production in Crohn's disease (CD).
METHODS: Surgical and endoscopic specimens from both inflamed and non-inflamed areas of the ileum and/or colon were collected from 20 and 14 adult CD patients, respectively, and used for the assessment of RAGE expression by means of immunohistochemistry and western blotting analysis. Normal tissues from 21 control subjects were used for comparison. The same polyclonal anti-human RAGE antibody (R and D System) was used in all experimental conditions. RAGE staining was quantized by a score including both the amount of positive cells and intensity of immunoreactivity; cellular pattern was also described. The effects of RAGE blocking on apoptotic rate and TNF-α production were investigated on immune cells freshly isolated from CD mucosa and incubated both with and without the muramyl dipeptide used as antigenic stimulus. Statistical analysis was performed via the test for trend, with regression models to account for intra-patient correlations. A 2-sided P < 0.05 was considered significant.
RESULTS: In inflamed areas, RAGE expression in both the epithelial and lamina propria compartments was higher than control tissues (P = 0.001 and 0.021, respectively), and a cluster of positive cells were usually found in proximity of ulcerative lesions. Similar results were obtained in the lamina propria compartment of non-inflamed areas (P = 0.025). The pattern of staining was membranous and granular cytosolic at the epithelial level, while in the lamina propria it was diffuse cytosolic. When evaluating the amount of protein expression by immunoblotting, a significant increase of both surface area and band intensity (P < 0.0001 for both) was observed in CD inflamed areas compared to control tissue, while in non-inflamed areas a significant increase was found only for band intensity (P < 0.005). Moreover, a significantly lower expression in non-inflamed areas in comparison with inflamed areas was found for both surface area and band intensity (P < 0.0006 for both). Finally, RAGE blocking largely affects both the apoptotic rate of mucosal cells (towards an increase in both non-inflamed and inflamed areas of P < 0.001 and < 0.0001, respectively) and TNF-α secretion (towards a decrease in both non-inflamed and inflamed areas of P < 0.05 and < 0.01, respectively), mainly in the presence of antigenic stimulation.
CONCLUSION: RAGE is up-regulated in CD, especially in inflamed areas, and it appears to play a role in the mechanisms involved in chronic inflammation.
© 2013 Baishideng Publishing Group Co., Limited. All rights reserved.

Entities:  

Keywords:  Apoptosis; Chronic inflammation; Crohn’s disease; Immunohistochemistry; Receptor for advanced glycation end products; Tumor necrosis factor-α

Mesh:

Substances:

Year:  2013        PMID: 24363518      PMCID: PMC3857450          DOI: 10.3748/wjg.v19.i45.8269

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

1.  Receptor for advanced glycation endproducts mediates neutrophil migration across intestinal epithelium.

Authors:  Ke Zen; Celia X-J Chen; Yi-Tien Chen; Rosemarie Wilton; Yuan Liu
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

2.  The functional -374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease.

Authors:  Jan Däbritz; Frauke Friedrichs; Toni Weinhage; Jochen Hampe; Torsten Kucharzik; Andreas Lügering; Ulrich Broeckel; Stefan Schreiber; Tilmann Spieker; Monika Stoll; Dirk Foell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-10       Impact factor: 4.052

3.  Apoptosis resistance of mucosal lymphocytes and IL-10 deficiency in patients with steroid-refractory Crohn's disease.

Authors:  Rebeca Santaolalla; Josep Mañé; Elisabet Pedrosa; Violeta Lorén; Fernando Fernández-Bañares; Josefa Mallolas; Anna Carrasco; Antonio Salas; Mercè Rosinach; Montserrat Forné; Jorge C Espinós; Carme Loras; Michael Donovan; Pere Puig; Miriam Mañosa; Miquel A Gassull; Josep M Viver; Maria Esteve
Journal:  Inflamm Bowel Dis       Date:  2010-11-08       Impact factor: 5.325

Review 4.  HMGB1 in systemic lupus Erythematosus: Its role in cutaneous lesions development.

Authors:  D A Abdulahad; J Westra; P C Limburg; C G M Kallenberg; M Bijl
Journal:  Autoimmun Rev       Date:  2010-05-21       Impact factor: 9.754

Review 5.  Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases.

Authors:  Warren Strober; Ivan J Fuss
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

6.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

Authors:  J Satsangi; M S Silverberg; S Vermeire; J-F Colombel
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

Review 7.  HMGB1 and RAGE in inflammation and cancer.

Authors:  Gary P Sims; Daniel C Rowe; Svend T Rietdijk; Ronald Herbst; Anthony J Coyle
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

Review 8.  Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.

Authors:  Velandai Srikanth; Annette Maczurek; Thanh Phan; Megan Steele; Bernadette Westcott; Damian Juskiw; Gerald Münch
Journal:  Neurobiol Aging       Date:  2009-05-22       Impact factor: 4.673

Review 9.  Crohn's disease: NOD2, autophagy and ER stress converge.

Authors:  Teresa Fritz; Lukas Niederreiter; Timon Adolph; Richard S Blumberg; Arthur Kaser
Journal:  Gut       Date:  2011-01-19       Impact factor: 23.059

Review 10.  RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation.

Authors:  Louis J Sparvero; Denise Asafu-Adjei; Rui Kang; Daolin Tang; Neilay Amin; Jaehyun Im; Ronnye Rutledge; Brenda Lin; Andrew A Amoscato; Herbert J Zeh; Michael T Lotze
Journal:  J Transl Med       Date:  2009-03-17       Impact factor: 5.531

View more
  13 in total

1.  Association between serum soluble receptor for advanced glycation end-products (RAGE) deficiency and severity of clinicopathologic evidence of canine chronic inflammatory enteropathy.

Authors:  Angela Isabel Cabrera-García; Jan S Suchodolski; Jörg M Steiner; Romy M Heilmann
Journal:  J Vet Diagn Invest       Date:  2020-07-27       Impact factor: 1.279

Review 2.  The role of the gut microbiota in NAFLD.

Authors:  Christopher Leung; Leni Rivera; John B Furness; Peter W Angus
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-08       Impact factor: 46.802

3.  The Circulating Level of Soluble Receptor for Advanced Glycation End Products Displays Different Patterns in Ulcerative Colitis and Crohn's Disease: A Cross-Sectional Study.

Authors:  Rachele Ciccocioppo; Venerina Imbesi; Elena Betti; Vincenzo Boccaccio; Peter Kruzliak; Alessandra Gallia; Giuseppina Cristina Cangemi; Gabriella Carnevale Maffe; Alessandro Vanoli; Serena Merante; Mara De Amici; Colomba Falcone; Catherine Klersy; Gino Roberto Corazza
Journal:  Dig Dis Sci       Date:  2015-03-11       Impact factor: 3.199

4.  Moxibustion attenuates inflammation in intestinal mucosal by regulating RAGE-mediated TLR4-NF-κBp65 signaling pathway in vivo and in vitro.

Authors:  Bingrong Li; Long Yuan; Peng Liu; Zixiang Geng; Kaiyong Zhang; Huiru Jiang; Hua Sui; Bimeng Zhang
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

Review 5.  Glycation & the RAGE axis: targeting signal transduction through DIAPH1.

Authors:  Alexander Shekhtman; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Expert Rev Proteomics       Date:  2016-12-22       Impact factor: 3.940

6.  E-type prostanoid receptor 4 drives resolution of intestinal inflammation by blocking epithelial necroptosis.

Authors:  Jay V Patankar; Tanja M Müller; Srinivas Kantham; Miguel Gonzalez Acera; Fabrizio Mascia; Kristina Scheibe; Mousumi Mahapatro; Christina Heichler; Yuqiang Yu; Wei Li; Barbara Ruder; Claudia Günther; Moritz Leppkes; Mano J Mathew; Stefan Wirtz; Clemens Neufert; Anja A Kühl; Jay Paquette; Kevan Jacobson; Raja Atreya; Sebastian Zundler; Markus F Neurath; Robert N Young; Christoph Becker
Journal:  Nat Cell Biol       Date:  2021-07-08       Impact factor: 28.824

Review 7.  Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications.

Authors:  R K Boyapati; A G Rossi; J Satsangi; G-T Ho
Journal:  Mucosal Immunol       Date:  2016-03-02       Impact factor: 7.313

8.  5-Fluorouracil Induces Enteric Neuron Death and Glial Activation During Intestinal Mucositis via a S100B-RAGE-NFκB-Dependent Pathway.

Authors:  Deiziane V S Costa; Ana C Bon-Frauches; Angeline M H P Silva; Roberto C P Lima-Júnior; Conceição S Martins; Renata F C Leitão; Gutierrez B Freitas; Patricia Castelucci; David T Bolick; Richard L Guerrant; Cirle A Warren; Vivaldo Moura-Neto; Gerly A C Brito
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

9.  The Association between Glyceraldehyde-Derived Advanced Glycation End-Products and Colorectal Cancer Risk.

Authors:  So Yeon Kong; Masayoshi Takeuchi; Hideyuki Hyogo; Gail McKeown-Eyssen; Sho-Ichi Yamagishi; Kazuaki Chayama; Peter J O'Brien; Pietro Ferrari; Kim Overvad; Anja Olsen; Anne Tjønneland; Marie-Christine Boutron-Ruault; Nadia Bastide; Franck Carbonnel; Tilman Kühn; Rudolf Kaaks; Heiner Boeing; Krasimira Aleksandrova; Antonia Trichopoulou; Pagona Lagiou; Effie Vasilopoulou; Giovanna Masala; Valeria Pala; Maria Santucci De Magistris; Rosario Tumino; Alessio Naccarati; H B Bueno-de-Mesquita; Petra H Peeters; Elisabete Weiderpass; J Ramón Quirós; Paula Jakszyn; María-José Sánchez; Miren Dorronsoro; Diana Gavrila; Eva Ardanaz; Martin Rutegård; Hanna Nyström; Nicholas J Wareham; Kay-Tee Khaw; Kathryn E Bradbury; Isabelle Romieu; Heinz Freisling; Faidra Stavropoulou; Marc J Gunter; Amanda J Cross; Elio Riboli; Mazda Jenab; W Robert Bruce
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-09-24       Impact factor: 4.254

Review 10.  Receptor for advanced glycation end-products axis and coronavirus disease 2019 in inflammatory bowel diseases: A dangerous liaison?

Authors:  Armando Rojas; Iván Schneider; Cristian Lindner; Ileana Gonzàlez; Miguel Angel Morales
Journal:  World J Gastroenterol       Date:  2021-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.